Key result
Biomarkers aid diagnosis and disease monitoring across all phases of aortic dissection management.
This review highlights the potential utility of biomarkers in the diagnosis and ongoing monitoring of patients with aortic dissection.
Hypothesis-generating for biomarker use in aortic dissection; leaves open clinical adoption pending prospective validation.
No takes yet. Share an insight, caveat, or question.
Segreto et al. (2014) studied this question. Biomarkers play a role in the diagnosis and disease monitoring of aortic dissection before, during, and after treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: